Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F5V7F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,464
Award facts
- Contract value 100% obligated
- $11,464.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 14, 2026, for TALTZ 80 MG/ML autoinjector with a firm fixed-price contract value of $11,464.32 and a completion date of January 15, 2026. This non-set-aside competitive award will be performed at the contractor's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication commonly used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis, demonstrating the DLA's ongoing procurement of specialty pharmaceutical products for military healthcare programs.
This delivery order is executed under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999 prime vendor vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military treatment facilities and veteran healthcare systems worldwide. Amerisourcebergen's established role as a critical pharmaceutical distributor to federal agencies, combined with its competitive positioning under this major DLA contract vehicle, underscores the company's strategic importance in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F5V7F?
SPE2DR26F5V7F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F5V7F worth?
The government has obligated $11,464 on SPE2DR26F5V7F.
Is contract SPE2DR26F5V7F an order under another contract?
Yes. SPE2DR26F5V7F is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5V7F competed?
The extent of competition for SPE2DR26F5V7F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award